Cava has been reporting high sales and comparable sales growth. It has been profitable since its first quarter as a public company in 2023. Cava stock trades at a high valuation. Cava is one of ...
[13] reported 3 cases of SVC syndrome due to SVC stenosis. The authors did not comment as to whether the ablation procedure itself was a risk factor for development of the syndrome, but the study ...
Feb. 10, 2025 — New research has found exposure to outdoor air pollution and extreme temperatures during pregnancy may increase the risk of prolonged pregnancy, offering new insights into the ...
CAVA has the potential to become a household name over the long run, but its current stock valuation is extremely high. We conducted a 20-year DCF analysis on CAVA, using very generous assumptions ...
This study aimed to investigate the prevalence of metabolic syndrome in women who experienced a complicated pregnancy 6 months earlier. Methods: This observational study investigated the prevalence of ...
Diagnosis Superior vena cava syndrome due to thrombotic obstruction---a complication of a cardiac procedure. Management Anticoagulation, catheter-directed thrombolytic therapy, mechanical ...
Cava Group (CAVA) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Introduction: In the fetus, a large proportion of the superior vena cava blood flow (Q SVC ... increased significantly during the second half of pregnancy (p < 0.001) while the mean Q SVC normalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results